LINC01582

Across TCGA pan-cancer cohorts, LINC01582 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01582 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC01582 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01582 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

LIHC, BLCA, and KIRC are the cancer types where LINC01582 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.286	0.638	<.001	81	view →
BLCA	OS	Tertile	All	0.598	0.724	.012	60	view →
KIRC	OS	Tertile	All	0.456	0.674	.003	48	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
READ	DFS	Tertile	III,IV	0.082	0.749	<.001	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	30	view →
SKCM	OS	Tertile	II,III,IV	0.128	0.335	.007	21	view →
ESCA	OS	Tertile	IV	0.743	0.323	.017	18	view →
ACC	OS	Tertile	II,III,IV	0.214	0.790	.012	18	view →
PCPG	OS	Tertile	All	0.723	0.975	.002	18	view →
STAD	OS	Quartile	IV	0.661	0.264	.028	6	view →
PAAD	OS	Tertile	II,III,IV	0.684	0.338	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01582–LIHC (OS)

Open the LIHC breakdown →